Myrobalan Therapeutics
PrivateLast Round
Grant
Mar 13, 2025
Total Funding Raised
$35.25M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Myrobalan Therapeutics operates in Healthcare & Life Sciences and is based in Medford, Massachusetts. Its latest recorded funding round was a Grant round in March 2025.
Myrobalan Therapeutics is a biotechnology company that develops oral neurorestorative therapies designed to reverse the underlying pathologies of brain dysfunctions and central nervous system conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myrobalan Therapeutics Comparables
Compare Myrobalan Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Progentos Therapeutics | 86% | |
| Pheno Therapeutics | 85% | |
| Sundance Biosciences | 85% |
For institutional investors. Book with your work email.
Myrobalan Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 13, 2025 | ||||
| Grant | Feb 7, 2024 | ||||
| Series A | Jan 10, 2024 | ||||
| Seed | Apr 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Myrobalan Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Bencao Capital | Series A, Seed |
| Co-Win Ventures | Series A |
| National MS Society | Grant |
| Ab Magnitude Ventures Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 48% MoM, reaching 6.1K.
- Jul 24, 2026
Monthly visitors grew 70% MoM, reaching 4.1K.
For institutional investors. Book with your work email.
Myrobalan Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Myrobalan Therapeutics's valuation, stock price, and market status.
Is Myrobalan Therapeutics a public or private company?
Myrobalan Therapeutics is a private company.
What is the current stock price of Myrobalan Therapeutics?
Myrobalan Therapeutics is a private company, so its shares have no public market price. Caplight tracks Myrobalan Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Myrobalan Therapeutics worth (valuation)?
Valuation information for Myrobalan Therapeutics is not publicly available.
Can I buy Myrobalan Therapeutics stock?
Myrobalan Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Myrobalan Therapeutics's last funding round?
Myrobalan Therapeutics's most recent funding round was Grant on March 13, 2025.
Who are the main investors in Myrobalan Therapeutics?
Key investors in Myrobalan Therapeutics include Co-Win Ventures.
Will Myrobalan Therapeutics IPO soon?
No public IPO plans have been announced for Myrobalan Therapeutics.
How can I track Myrobalan Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Myrobalan Therapeutics's shares on secondary markets.